P42574 (CASP3_HUMAN) Homo sapiens (Human)

Caspase-3 UniProtKBInterProSTRINGInteractive Modelling

277 aa; Sequence (Fasta) ; 1 identical sequence: Pan paniscus: A0A2R9A7H9

Available Structures

135 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Human caspase-3 in complex with Ac-ATS009-KE
6cl0
 Heteromer
29-277
Assess
Human caspase-3 in complex with Ac-DW3-KE
6ckz
 Heteromer
29-277
Assess
Caspase-3:CAS329306
2xyg
 Heteromer
29-277
2×TQ8;
Assess
Crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors.
2cnl
 Heteromer
29-277
Assess
Crystal structure of caspase-3 with inhibitor Ac-DEVD-Cho
2h5i
 Heteromer
29-277
Assess
Crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors.
2cdr
 Heteromer
29-277
Assess
Crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors.
2cnk
 Heteromer
29-277
Assess
Crystal structures of caspase-3 in complex with aza-peptide Michael acceptor inhibitors.
2c1e
 Heteromer
29-277
Assess
Caspase-3:CAS26049945
2xyp
 Heteromer
29-277
2×XVE;
Assess
Crystal structures of caspase-3 in complex with aza-peptide Michael acceptor inhibitors.
2c2k
 Heteromer
29-277
Assess
Caspase-3:CAS60254719
2xyh
 Heteromer
29-277
2×TQ9;
Assess
Crystal structures of caspase-3 in complex with aza-peptide Michael acceptor inhibitors.
2c2m
 Heteromer
29-277
Assess
Crystal structures of caspase-3 in complex with aza-peptide Michael acceptor inhibitors.
2c2o
 Heteromer
29-277
Assess
THE 2.8 ANGSTROM CRYSTAL STRUCTURE OF CASPASE-3 (APOPAIN OR CPP32)IN COMPLEX WITH AN ISATIN SULFONA…
1gfw
 Heteromer
29-277
1×MSI;
Assess
CRYSTAL STRUCTURE OF THE COMPLEX OF XIAP-BIR2 AND CASPASE 3
1i3o
 Heteromer
P98170; 		32-276
2×ZN;
Assess
Crystal Structure of Caspase-3 with Peptide Inhibitor Ac-VDV(DAB)D-CHO
7seo
 Heteromer
33-277
Assess
Crystal structure of caspase-3 with inhibitor Ac-VDFVD-CHO
7rn9
 Heteromer
34-277
Assess
Crystal Structure of caspase 3, L168F mutant
4dcp
 Heteromer
34-277
Assess
Crystal structure of caspase 3, L168D mutant
4dcj
 Heteromer
34-277
Assess
Crystal Structure of caspase 3, L168Y mutant
4dco
 Heteromer
34-277
Assess
Crystal structure of caspase-3 with inhibitor Ac-VDRVD-CHO
7rnb
 Heteromer
34-277
Assess
Crystal structure of caspase-3 with inhibitor Ac-VD(Orn)VD-CHO
7rn8
 Heteromer
34-277
Assess
Caspase-3 Binds Diverse P4 Residues in Peptides
3gjs
 Heteromer
34-277
Assess
Crystal structure of caspase-3 with inhibitor Ac-ITV(Dab)D-CHO
7rna
 Heteromer
34-277
Assess
Crystal structure of caspase-3 with inhibitor Ac-VDVVD-CHO
7rnc
 Heteromer
34-277
Assess
Crystal structure of Caspase 3 S150A
6bdv
 Heteromer
34-277
1×CL; 2×AZI;
Assess
Crystal strusture of caspase-3 with inhibitor Ac-DMQD-Cho
2h5j
 Heteromer
34-277
Assess
Caspase-3 in Complex with an Inhibitory DARPin-3.4_S76R
2y0b
 Heteromer
34-277
2×MPD; 1×MRD;
Assess
Caspase-3 in Complex with an Inhibitory DARPin-3.4
2xzd
 Heteromer
34-277
1×MRD; 1×MPD;
Assess
Crystal structure of caspase-3 with inhibitor Ac-VDKVD-CHO
7rnf
 Heteromer
34-277
Assess
Caspase-3 Binds Diverse P4 Residues in Peptides
3gjr
 Heteromer
34-277
1×DZE; 1×GOL;
Assess
Crystal strusture of caspase-3 with inhibitor Ac-VDVAD-Cho
2h65
 Heteromer
34-277
Assess
Caspase-3 in Complex with DARPin-3.4_I78S
2xzt
 Heteromer
34-277
2×MRD;
Assess
Crystal Structure of Caspase-3 with Peptide Inhibitor AcITV(Orn)D-CHO
7usp
 Heteromer
34-277
Assess
Crystal structure of caspase-3 with inhibitor Ac-VDPVD-CHO
7rnd
 Heteromer
34-276
Assess
Caspase-3 Binds Diverse P4 Residues in Peptides
3gjt
 Heteromer
34-276
Assess
Crystal Structure of Caspase-3 with Peptide Inhibitor AcITVKD-CHO
7uso
 Heteromer
34-276
Assess
Crystal structure of caspase-3 with inhibitor Ac-VD(Aly)VD-CHO
7rn7
 Heteromer
34-276
Assess
Caspase-3 Binds Diverse P4 Residues in Peptides
3gjq
 Heteromer
34-276
Assess
Crystal Structure of Caspase-3 with Peptide Inhibitor AcDVPD-CHO
7usq
 Heteromer
34-276
Assess
Crystal structure of caspase-3 with inhibitor Ac-YKPVD-CHO
7rne
 Heteromer
34-276
Assess
Crystal structure of caspase-3 with inhibitor Ac-ITAKD-CHO
7rng
 Heteromer
35-276
Assess
Crystal structure of caspase-3 DEVE peptide complex
5ic4
 Heteromer
35-276
Assess
Cryo-EM structure of CopC-CaM-caspase-3 with ADPR
7xn5
 Heteromer
P0DP23; Q7NWF2; 		35-276
1×NCA; 1×APR;
Assess
Cryo-EM structure of CopC-CaM-caspase-3 with ADPR-deacylization
7xn6
 Heteromer
P0DP23; Q7NWF2; 		35-276
1×APR; 1×NCA;
Assess
Cryo-EM structure of CopC-CaM-caspase-3 with NAD+
7xn4
 Heteromer
P0DP23; Q7NWF2; 		35-276
1×NAD;
Assess
Extended substrate recognition in caspase-3 revealed by high resolution X-ray structure analysis
2dko
homo-4-mer29-277
Assess
The Role of Loop Bundle Hydrogen Bonds in the Maturation and Activity of(Pro)caspase-3
2j32
homo-4-mer29-277
Assess
The Role of Loop Bundle Hydrogen Bonds in the Maturation and Activity of (Pro)caspase-3
2j30
homo-4-mer29-277
Assess
The Role of Loop Bundle Hydrogen Bonds in the Maturation and Activity of(Pro)caspase-3
2j31
homo-4-mer29-277
Assess
Crystal structure of Pseudo-activated Procaspase-3
3itn
homo-4-mer29-277
Assess
Extended substrate recognition in caspase-3 revealed by high resolution X-ray structure analysis
2cjy
homo-4-mer29-277
Assess
Extended substrate recognition in caspase-3 revealed by high resolution X-ray structure analysis
2cjx
homo-4-mer29-277
Assess
Crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors.
2cnn
homo-4-mer29-277
Assess
Crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors.
2cno
homo-4-mer29-277
Assess
The Role of Loop Bundle Hydrogen Bonds in the Maturation and Activity of (Pro)caspase-3
2j33
homo-4-mer29-277
Assess
Caspase-3 in complex with ketomethylene inhibitor reveals tetrahedral adduct
6x8i
homo-4-mer34-277
Assess
Crystal structure of Caspase-3 with inhibitor AC-LDESD-CHO
3edq
homo-4-mer34-277
Assess
Caspase 3 Bound to a covalent inhibitor
3kjf
homo-4-mer34-277
2×B92;
Assess
CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PRYAZINONE INHIBITOR
1rhj
homo-4-mer34-276
2×PZN;
Assess
CRYSTAL STRUCTURE OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR
1re1
homo-4-mer34-276
2×NA3;
Assess
Crystal structure of the complex of caspase-3 with a phenyl-propyl-ketone inhibitor
1rhk
homo-4-mer34-276
Assess
CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR
1rhm
homo-4-mer34-276
2×NA4;
Assess
CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A 5,6,7 TRICYCLIC PEPTIDOMIMETIC INHIBITOR
1rhu
homo-4-mer34-276
2×3CY;
Assess
CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A CINNAMIC ACID METHYL ESTER INHIBITOR
1rhr
homo-4-mer34-276
2×CNE;
Assess
CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A BROMOMETHOXYPHENYL INHIBITOR
1rhq
homo-4-mer34-276
2×0ZZ;
Assess
Caspase-3 in complex with elongated ketomethylene inhibitor
6x8k
homo-4-mer35-276
Assess
Caspase 3 V266M
5ibp
homo-2-mer29-277
4×AZI;
Assess
Caspase-3 T140GV266H
4quj
homo-2-mer29-277
2×NA; 4×AZI; 2×MPD;
Assess
Caspase-3 Mutant- T245D
6bfo
homo-2-mer29-277
11×NA; 2×AZI;
Assess
Caspase 3 V266Y
5ias
homo-2-mer29-277
2×NA;
Assess
Caspase-3 Mutant - T245D,S249D
6bfj
homo-2-mer29-277
1×AZI;
Assess
Caspase 3 V266F
5iae
homo-2-mer29-277
2×CL; 1×ACT;
Assess
Caspase-3 F128A
4qu9
homo-2-mer29-277
12×AZI;
Assess
Caspase 3 V266L
5iaj
homo-2-mer29-277
2×NA;
Assess
Caspase-3 Mutant - S150Y
6bgs
homo-2-mer29-277
Assess
Structure of Casp-3 with tethered salicylate
1nme
homo-2-mer29-277
1×158; 1×159;
Assess
Caspase-3 E190A
4qty
homo-2-mer29-277
2×NA; 2×AZI;
Assess
Caspase-3 Mutant - T152V
6bha
homo-2-mer29-277
Assess
Caspase 3 V266I
5ibc
homo-2-mer29-277
2×NA;
Assess
Caspase-3 K137A
4qub
homo-2-mer29-277
10×AZI;
Assess
Caspase-3 M61A V266H
4qu8
homo-2-mer29-277
2×CL; 2×DTT;
Assess
Caspase-3 Mutant- T245A
6bfk
homo-2-mer29-277
3×NA;
Assess
Caspase-3 F128AV266H
4qui
homo-2-mer29-277
2×DTT; 2×CL;
Assess
Caspase 3 V266W
5iar
homo-2-mer29-277
2×NA; 2×DTT;
Assess
Caspase 3 V266A
5i9b
homo-2-mer29-277
2×NA;
Assess
Caspase 3 V266S
5iak
homo-2-mer29-277
2×NA;
Assess
Caspase-3 Mutant- D9A,D28A,T152D
6bgk
homo-2-mer29-277
2×CL; 1×AZI;
Assess
Caspase-3 Mutant - D9A,D28A,S150E
6bg1
homo-2-mer29-277
1×NA;
Assess
Caspase-3 Y195F
4qua
homo-2-mer29-277
Assess
Caspase-3 F55W
4qul
homo-2-mer29-277
3×AZI;
Assess
Caspase-3 T140V
4qu5
homo-2-mer29-277
Assess
Caspase-3 Mutant - T152A
6bh9
homo-2-mer29-277
3×NA; 1×CL;
Assess
Caspase 3 V266C
5i9t
homo-2-mer29-277
1×ACT;
Assess
Caspase-3 Y195AV266H
4qu0
homo-2-mer29-277
2×AZI;
Assess
Caspase-3 Mutant - S150D
6bgq
homo-2-mer29-277
1×CL; 5×AZI;
Assess
Caspase-3 Mutant - S150E
6bgr
homo-2-mer29-277
4×AZI;
Assess
Caspase 3 V266N
5ian
homo-2-mer29-277
2×NA;
Assess
Caspase-3 Y195A
4qtx
homo-2-mer29-276
2×ACT;
Assess
Caspase-3 T140F
4qud
homo-2-mer29-276
Assess
Crystal Structures of Caspase-3 with Bound Isoquinoline-1,3,4-trione Derivative Inhibitors
3dei
homo-2-mer33-277
Assess
Caspase-3 tethered to irreversible inhibitor
1nms
homo-2-mer34-277
2×161;
Assess
Caspase 3 V266K
5ibr
homo-2-mer34-277
Assess
Caspase 3 V266D
5iab
homo-2-mer34-277
1×DTT;
Assess
Human procaspase-3 bound to Ac-DEVD-CMK
4jr0
homo-2-mer34-277
2×CL;
Assess
Caspase-3 Mutant- D9A,D28A,T245D
6bfl
homo-2-mer34-277
1×AZI;
Assess
Caspase-3 Mutant - D9A,D28A,S150D
6bg0
homo-2-mer34-277
1×NA; 2×AZI;
Assess
Crystal Structures of Caspase-3 with Bound Isoquinoline-1,3,4-trione Derivative Inhibitors
3dek
homo-2-mer34-277
1×RXD;
Assess
Extendend Tethering: In Situ Assembly of Inhibitors
1nmq
homo-2-mer34-277
2×160;
Assess
Human procaspase-3, crystal form 1
4jqy
homo-2-mer34-277
Assess
Crystal Structures of Caspase-3 with Bound Isoquinoline-1,3,4-trione Derivative Inhibitors
3deh
homo-2-mer34-277
Assess
Crystal Structures of Caspase-3 with Bound Isoquinoline-1,3,4-trione Derivative Inhibitors
3dej
homo-2-mer34-277
Assess
Human procaspase-3, crystal form 2
4jqz
homo-2-mer34-277
Assess
Caspase-3 T140G
4quh
homo-2-mer34-276
2×MRD; 4×AZI; 1×DTT;
Assess
Caspase-3 Y195FV266H
4que
homo-2-mer34-276
1×DTT; 2×AZI;
Assess
Caspase-3 Mutant- T152D
6bg4
homo-2-mer34-276
5×NA; 1×CL; 1×AZI;
Assess
Conformational restrictions in the active site of unliganded human caspase-3
1qx3
homo-2-mer35-277
Assess
Caspase-3 M61A
4qug
homo-2-mer34-276
1×CL; 1×ACT; 3×AZI;
Assess
3,4-Dihydropyrimido(1,2-a)indol-10(2H)-ones as Potent Non-Peptidic Inhibitors of Caspase-3
3h0e
homo-2-mer34-276
2×H0E;
Assess
CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE INHIBITOR ACE-DVAD-FMC
1cp3
homo-2-mer35-277
Assess
Crystal structure of the complex of apopain with the tetrapeptide aldehyde inhibitor AC-DEVD-CHO
1pau
homo-2-mer34-276
Assess
Caspase-3 specific unnatural amino acid peptides
4jje
monomer29-277
Assess
Caspase-3 E246A, K242A Double Mutant
3pcx
monomer29-277
Assess
Allosteric Modulation of Caspase-3 through Mutagenesis
4ehd
monomer29-277
Assess
Allosteric Modulation of Caspase-3 through Mutagenesis
4ehf
monomer29-277
Assess
Caspase-8 specific unnatural amino acid peptides
4pry
monomer29-277
Assess
Caspase 3 V266Q
5iag
monomer29-277
Assess
Caspase-3 E246A
3pd0
monomer29-277
1×CL;
Assess
Caspase-3 K242A
3pd1
monomer30-277
Assess
Allosteric Modulation of Caspase-3 through Mutagenesis
4ehh
monomer33-277
Assess
Caspase-8 specific unnatural amino acid peptides
4ps0
monomer34-277
Assess
Allosteric Modulation of Caspase-3 through Mutagenesis
4ehn
monomer34-276
Assess
Allosteric Modulation of Caspase-3 through Mutagenesis
4ehk
monomer35-276
Assess
Allosteric Modulation of Caspase-3 through Mutagenesis
4eha
monomer35-276
Assess
Allosteric Modulation of Caspase-3 through Mutagenesis
4ehl
monomer35-276
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5ibc.1.Bhomo-2-mer0.8029-277
2×ACE;99.64
Assess